Repligen Q4 revenue down 16.6% to $155.7M; net loss $0.46/share

REPLIGEN CORP

2023-FY EPS reported $0.74 revenue$638,764,000

Q4 2023 revenue $155.7M vs $186.8M in Q4 2022; full year $638.8M vs $801.5M.
GAAP net loss $25.5M ($0.46 per diluted share) vs profit of $48.7M ($0.85) in Q4 2022.
Adjusted EPS $0.33 vs $0.68; book-to-bill ratio 1.03 for second straight quarter.
FY2024 guidance: revenue $620M-$650M, adjusted EPS $1.42-$1.49.
Closed Metenova acquisition; launched TangenX SC; issued $600M convertible notes.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.95

REPLIGEN CORP reported financial results for the fourth quarter and year end December 31, 2023.

Period: the fourth quarter and year end December 31, 2023
Result: reported results

Exact text from the filing

On February 21, 2024, Repligen Corporation announced its financial results for the fourth quarter and year end December 31, 2023.

View on SEC.gov

379 earnings releases filed in the last 30 days. Browse all earnings releases →

REPLIGEN CORP filing history →

Source: SEC EDGAR

accession 0001193125-24-040727

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.